Attached files

file filename
10-K - FORM 10-K - PharMerica CORPd10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PharMerica CORPdex211.htm
EX-31.1 - 302 CERTIFICATION OF THE CEO - PharMerica CORPdex311.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - PharMerica CORPdex232.htm
EX-31.2 - 302 CERTIFICATION OF THE CFO - PharMerica CORPdex312.htm
EX-32.1 - 906 CERTIFICATION OF THE CEO - PharMerica CORPdex321.htm
EX-23.1 - CONSENT OF KPMG LLP - PharMerica CORPdex231.htm
EX-10.40 - AMENDED AND RESTATED PRIME VENDOR AGREEMENT - PharMerica CORPdex1040.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of PharMerica Corporation (the “Corporation”) on Form 10-K for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael J. Culotta, Executive Vice President and Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

 

/S/    MICHAEL J. CULOTTA        

Michael J. Culotta

Executive Vice President and Chief Financial Officer

February 24, 2011